Followers | 206 |
Posts | 18506 |
Boards Moderated | 0 |
Alias Born | 10/30/2016 |
Tuesday, September 19, 2017 10:35:36 AM
Recent MBOT News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/15/2024 12:40:29 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/15/2024 12:40:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 12:38:15 PM
- Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 • GlobeNewswire Inc. • 10/15/2024 12:38:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 08:30:20 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/01/2024 12:10:21 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/01/2024 12:07:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 12:33:51 PM
- Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up • GlobeNewswire Inc. • 09/30/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 12:30:27 PM
- Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System • GlobeNewswire Inc. • 09/17/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 05:00:40 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/22/2024 03:36:31 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/22/2024 03:33:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 12:30:38 PM
- Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System • GlobeNewswire Inc. • 08/22/2024 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/15/2024 11:34:05 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/15/2024 11:32:11 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 05:15:42 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/13/2024 08:30:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/13/2024 08:30:46 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/13/2024 08:30:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:30:38 PM
- Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization • GlobeNewswire Inc. • 08/13/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 12:30:27 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM